For his part, Sam Stovall, chief investment strategist at Standard & Poor's, is talking about reversion to the mean, where last decade's winners will be this decade's laggards and vice versa. If that happens, he said you might want to keep a watchful eye on U.S. mid- and small-cap stocks; emerging market equities; and gold. And from a sector point of view, the same goes for energy and materials groups, and to a lesser extent, the consumer-oriented areas.
In the 2011-2020 decade, Stovall said health care and utilities may prevail while energy and materials take a back seat. Stocks in the health-care industry that had the highest rating from Standard & Poor's as of Jan. 18 include Celgene Corp. (NYSE: CELG - News), Dr. Reddy's Labs Ltd. (NYSE: RDY - News), Life Technologies Corp. (NYSE: LIFE - News), Vertex Pharmaceuticals Inc. (NYSE: VRTX - News), Thermo Fisher Scientific Inc. (NYSE: TMO - News), Mylan Laboratories Inc. (NYSE: MYL - News), Express Scripts Inc. (NYSE: ESRX - News), Medco Health Solutions Inc. (NYSE: MHS - News), and McKesson Corp. (NYSE: MCK - News). Stocks in the utilities industry that had the highest rating from Standard & Poor's include ITC Holdings Corp. (NYSE: ITC - News) and Oneok Inc. (NYSE: OKE - News).